1,170
Views
46
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Does Eczema Lead to Asthma?

, M.B.B.S., F.R.A.C.P., M.Epid., , B.B.Sc., M.P.H., Ph.D., , B.Sc., M.App.Sc., Ph.D., , M.B.B.S., Ph.D., F.A.C.D., , M.B.B.S., B.Med.Sc(Hons.)., F.R.A.C.P., Ph.D., F.A.F.P.H.M. & , M.B.B.S., M.D., M.Sc., Ph.D.
Pages 429-436 | Published online: 21 Jul 2009

References

  • Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351(9111)1225–1232
  • Williams H, Robertson C, Stewart A, Ait-Khaled N, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103(1)125–138, (Pt 1)
  • European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9: 687–695
  • Moorman J E, Rudd R A, Johnson C A, King M, et al. Centers for Disease Control and Prevention. National Surveillance for Asthma—United States, 1980–2004. Surveillance Summaries, October 19. MMWR 2007; 56(SS-8), 2007
  • Simpson E L, Hanifin J M. Atopic dermatitis. Med Clin North Am 2006; 90: 149–167; ix
  • Asher M I, Montefort S, Bjorksten B, Lai C K, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537)733–743
  • Sly R M. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999; 82: 233–248, quiz 248–252
  • Pearce N, Douwes J. The global epidemiology of asthma in children. Int J Tuberc Lung Dis 2006; 10: 125–132
  • Robertson C F, Roberts M F, Kappers J H. Asthma prevalence in Melbourne schoolchildren: have we reached the peak?. Med J Aust 2004; 180: 273–276
  • Ponsonby A L, Glasgow N, Pezic A, Dwyer T, et al. A temporal decline in asthma but not eczema prevalence from 2000 to 2005 at school entry in the Australian Capital Territory with further consideration of country of birth. Int J Epidemiol 2008; 37: 559–569
  • Pearce N, Ait-Khaled N, Beasley R, Mallol J, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 758–766
  • Bergmann R L, Edenharter G, Bergmann K E, Forster J, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998; 28: 965–970
  • Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis—a prospective follow-up to 7 years of age. Allergy 2000; 55: 240–245
  • van d er, Hulst A E, Klip H, Brand P L. Risk of developing asthma in young children with atopic eczema: A systematic review. J Allergy Clin Immunol 2007; 120: 565–569
  • Hanifin J M, Reed M L. A population-based survey of eczema prevalence in the United States. Dermatitis 2007; 18: 82–91
  • Martin Fernandez-Mayoralas D, Martin Caballero J M, Garcia-Marcos Alvarez L. [Association between atopic dermatitis, allergic rhinitis and asthma in schoolchildren aged 13–14 years old]. An Pediatr (Barc) 2004; 60: 236–242
  • Hakansson K, Thomsen S F, Ulrik C S, Porsbjerg C, et al. Increase in the prevalence of rhinitis among Danish children from 1986 to 2001. Pediatr Allergy Immunol, 2007; 18: 154–159
  • Spergel J M, Paller A S. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112(6 suppl)S118–127
  • Simpson E L, Hanifin J M. Atopic dermatitis. J Am Acad Dermatol 2005; 53: 115–128
  • Food Allergy, Atopic Dermatitis and the Allergy March. Proceedings of a symposium in honour of Professor Luisa Businco, VeniceItaly, November 17–19, 2000, 5–107, Pediatr Allergy Immunol 2001; 12 (suppl 14)
  • Wüthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999; 83: 464–470
  • Wüthrich B, Schudel P. [Atopic neurodermatitis after childhood stage; follow-up study of 121 cases]. Z Hautkr 1983; 58: 1013–1023
  • Kissling S, Wüthrich B. [Follow-up of atopic dermatitis after early childhood]. Hautarzt 1993; 44: 569–573
  • Illi S, von Mutius E, Lau S, Nickel R, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925–931
  • Lowe A J, Abramson M J, Hosking C S, Carlin J B, et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clin Exp Allergy 2007; 37: 536–542
  • Almqvist C, Li Q, Britton W J, Kemp A S, et al. Early predictors for developing allergic disease and asthma: examining separate steps in the ‘allergic march’. Clin Exp Allergy 2007; 37: 1296–1302
  • Lowe A J, Carlin J B, Bennett C M, Hosking C S, et al. Do boys do the atopic march while girls dawdle?. J Allergy Clin Immunol 2008; 121: 1190–1195
  • Burgess J A, Dharmage S C, Byrnes G B, Matheson M C, et al. Childhood eczema and asthma incidence and persistence: a cohort study from childhood to middle age. J Allergy Clin Immunol 2008; 122: 280–285
  • Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328–340
  • McGrath J A, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med 2008; 14: 20–27
  • Nicotera P, Melino G. Caspase-14 and epidermis maturation. Nat Cell Biol 2007; 9: 621–622
  • Jakasa I, de Jongh C M, Verberk M M, Bos J D, et al. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006; 155: 104–109
  • Jakasa I, Verberk M M, Esposito M, Bos J D, et al. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol 2007; 127: 129–134
  • Arikawa J, Ishibashi M, Kawashima M, Takagi Y, et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119: 433–439
  • Imokawa G, Abe A, Jin K, Higaki Y, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J Invest Dermatol 1991; 96: 523–526
  • Strid J, Hourihane J, Kimber I, Callard R, et al. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 2004; 34: 2100–2109
  • Spergel J M, Mizoguchi E, Brewer J P, Martin T R, et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101: 1614–1622
  • Lowe A J, Hosking C S, Bennett C M, Carlin J B, et al. Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis. Clin Exp Allergy 2007; 37: 1624–1631
  • Lack G, Fox D, Northstone K, Golding J. Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003; 348: 977–985
  • Leung D Y. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860–876
  • Lee Y A, Wahn U, Kehrt R, Tarani L, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000; 26: 470–473
  • Cookson W O, Ubhi B, Lawrence R, Abecasis G R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001; 27: 372–373
  • Bradley M, Soderhall C, Luthman H, Wahlgren C F, et al. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 2002; 11: 1539–1548
  • Haagerup A, Bjerke T, Schiotz P O, Dahl R, et al. Atopic dermatitis – a total genome-scan for susceptibility genes. Acta Derm Venereol 2004; 84: 346–352
  • Hoffjan S, Epplen J T. The genetics of atopic dermatitis: recent findings and future options. J Mol Med 2005; 83: 682–692
  • Hoffjan S, Ober C. Genetic factors, in Lung biology in health and disease, C. Lenfant. Marcel Dekker, New York 2005
  • Chien Y H, Hwu W L, Chiang B L. The genetics of atopic dermatitis. Clin Rev Allergy Immunol 2007; 33: 178–190
  • Mischke D, Korge B P, Marenholz I, Volz A, et al. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21. J Invest Dermatol 1996; 106: 989–992
  • Compton J G, DiGiovanna J J, Johnston K A, Fleckman P, et al. Mapping of the associated phenotype of an absent granular layer in ichthyosis vulgaris to the epidermal differentiation complex on chromosome 1. Exp Dermatol 2002; 11: 518–526
  • Smith F J, Irvine A D, Terron-Kwiatkowski A, Sandilands A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337–342
  • Wells R. S., Kerr C. B. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. BMJ 1966; 1: 947–950
  • Seguchi T, Cui C Y, Kusuda S, Takahashi M, et al. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 1996; 288: 442–446
  • Palmer C N, Irvine A D, Terron-Kwiatkowski A, Zhao Y, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–446
  • Ruether A, Stoll M, Schwarz T, Schreiber S, et al. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006; 155: 1093–1094
  • Barker J N, Palmer C N, Zhao Y, Liao H, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127: 564–567
  • Stemmler S, Parwez Q, Petrasch-Parwez E, Epplen J T, et al. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 2007; 127: 722–724
  • Weidinger S, Rodriguez E, Stahl C, Wagenpfeil S, et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007; 127: 724–726
  • Irvine A D. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007; 127: 504–507
  • Morar N, Cookson W O, Harper J I, Moffatt M F. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007; 127: 1667–1672
  • Novak N, Baurecht H, Schafer T, Rodriguez E, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008; 128: 1430–1435
  • Ekelund E, Lieden A, Link J, Lee S P, et al. Loss-of-function variants of the filaggrin gene are associated with atopic eczema and associated phenotypes in Swedish families. Acta Derm Venereol 2008; 88: 15–19
  • Henderson J, Northstone K, Lee S P, Liao H, et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008; 121: 872–877; e9
  • Nomura T, Sandilands A, Akiyama M, Liao H, et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007; 119: 434–440
  • Gruber R, Janecke A R, Fauth C, Utermann G, et al. Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris. Eur J Hum Genet 2007; 15: 179–184
  • Hamada T, Sandilands A, Fukuda S, Sakaguchi S, et al. De novo occurrence of the filaggrin mutation p.R501X with prevalent mutation c.3321delA in a Japanese family with ichthyosis vulgaris complicated by atopic dermatitis. J Invest Dermatol 2008; 128: 1323–1325
  • Brown S J, Sandilands A, Zhao Y, Liao H, et al. Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J Invest Dermatol 2008; 128: 1591–1594
  • Giardina E, Paolillo N, Sinibaldi C, Novelli G. R501X and 2282del4 filaggrin mutations do not confer susceptibility to psoriasis and atopic dermatitis in Italian patients. Dermatology 2008; 216: 83–84
  • Cookson W O, Moffatt M F. The genetics of atopic dermatitis. Curr Opin Allergy Clin Immunol 2002; 2: 383–387
  • Marenholz I, Nickel R, Ruschendorf F, Schulz F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006; 118: 866–871
  • Weidinger S, O'Sullivan M, Illig T, Baurecht H, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008; 121: 1203–1209; e1
  • Brown S J, Relton C L, Liao H, Zhao Y, et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol 2008; 121: 940–946; e3
  • Gdalevich M, Mimouni D, David M, Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001; 45: 520–527
  • Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma in childhood: a systematic review with meta-analysis of prospective studies. J Pediatr 2001; 139: 261–266
  • Bergmann R L, Diepgen T L, Kuss O, Bergmann K E, et al. Breastfeeding duration is a risk factor for atopic eczema. Clin Exp Allergy 2002; 32: 205–209
  • Matheson M C, Erbas B, Balasuriya A, Jenkins M A, Wharton C L, Tang M LK, Abramson M J, Walters E H, Hopper J L, Dharmage S C. Breastfeeding and Atopic Disease: A Cohort Study from Childhood to Middle-age. J Allergy Clin Immunol, (provisionally accepted)
  • Sears M R, Greene J M, Willan A R, Taylor D R, et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet 2002; 360(9337)901–907
  • Lowe A J, Carlin J B, Bennett C M, Abramson M J, et al. Atopic disease and breast-feeding–cause or consequence?. J Allergy Clin Immunol 2006; 117: 682–687
  • Kramer M S, Matush L, Vanilovich I, Platt R, et al. Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial. BMJ 2007; 335(7624)815
  • Douwes J, Pearce N. Asthma and the westernization “package.”. Int J Epidemiol 2002; 31: 1098–1102
  • Braun-Fahrlander C. Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 2003; 3: 325–329
  • Illi S, von Mutius E, Lau S, Bergmann R, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001; 322(7283)390–395
  • Strachan D P, Taylor E M, Carpenter R G. Family structure, neonatal infection, and hay fever in adolescence. Arch Dis Child 1996; 74: 422–426
  • Strachan D P. Allergy and family size: a riddle worth solving. Clin Exp Allergy 1997; 27: 235–236
  • Oddy W H, de Klerk N H, Sly P D, Holt P G. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J 2002; 19: 899–905
  • Hesselmar B, Aberg N, Aberg B, Eriksson B, et al. Does early exposure to cat or dog protect against later allergy development?. Clin Exp Allergy 1999; 29: 611–617
  • Remes S T, Castro-Rodriguez J A, Holberg C J, Martinez F D, et al. Dog exposure in infancy decreases the subsequent risk of frequent wheeze but not of atopy. J Allergy Clin Immunol 2001; 108: 509–515
  • Svanes C, Jarvis D, Chinn S, Burney P. Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 103(3)415–420, Pt 1
  • Svanes C, Heinrich J, Jarvis D, Chinn S, et al. Pet-keeping in childhood and adult asthma and hay fever: European community respiratory health survey. J Allergy Clin Immunol 2003; 112: 289–300
  • Strachan D P. Family size, infection and atopy: the first decade of the “hygiene hypothesis.”. Thorax 2000; 55(suppl 1)S2–10
  • Jackson D J, Gangnon R E, Evans M D, Roberg K A, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178: 667–672
  • Kusel M M, de Klerk N H, Kebadze T, Vohma V, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119: 1105–1110
  • Stein R T, Sherrill D, Morgan W J, Holberg C J, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354(9178)541–545
  • Platts-Mills T, de Weck A. Dust mite allergens and asthma–a worldwide problem. J Allergy Clin Immunol 1989; 83(2)416–427, Pt 1
  • Sporik R, Holgate S T, Platts-Mills T A, Cogswell J J. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323: 502–507
  • Marks G B, Mihrshahi S, Kemp A S, Tovey E R, et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol 2006; 118: 53–61
  • Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol 2005; 116: 49–55
  • Woodcock A, Lowe L A, Murray C S, Simpson B M, et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med 2004; 170: 433–439
  • Arshad S H, Bateman B, Matthews S M. Primary prevention of asthma and atopy during childhood by allergen avoidance in infancy: a randomised controlled study. Thorax 2003; 58: 489–493
  • Horak F, Jr, Matthews S, Ihorst G, Arshad S H, et al. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study – 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin Exp Allergy 2004; 34: 1220–1225
  • Hill A B. The Environment and Disease: Association or Causation?. Proc R Soc Med 1965; 58: 295–300
  • Rothman K J, Poole C. A strengthening programme for weak associations. Int J Epidemiol 1988; 17: 955–959
  • Rothman K J, Greenland S. Modern Epidemiology. Lippincott, Raven, Philadelphia 1998; 295
  • Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008; 121: 1331–1336
  • Wahn U. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol 1998; 9: 116–124
  • Ross T, Ross G, Varigos G. Eczema–practical management issues. Aust Fam Phys 2005; 34: 319–324
  • Chamlin S L, Kao J, Frieden I J, Sheu M Y, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47: 198–208
  • Cheer S M, Plosker G L. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001; 2: 389–406
  • Nakagawa H. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan. Clin Drug Investig 2006; 26: 235–246
  • Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, et al. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. J Med Assoc Thai 2006; 89: 1915–1922
  • Wahn U, Bos J D, Goodfield M, Caputo R, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002; 110(1)e2, (Pt 1)
  • Boyle R J, Bath-Hextall F J, Leonardi-Bee J, Murrell D F, et al. Probiotics for treating eczema. Cochrane Database Syst Rev 2008, CD006135
  • Betsi G I, Papadavid E, Falagas M E. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol 2008; 9: 93–103
  • Wickens K, Black P N, Stanley T V, Mitchell E, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122: 788–794

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.